| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 14.00 to 16.00 % |
Dacomitinib
(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C24H25ClFN5O2 = 469.95 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | <0°C |
| CAS RN | 1110813-31-4 |
| Unit | Price |
| 100 mg | 7500 |
| 250 mg | 9750 |
| 1 g | 17500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
